Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData

The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework

Siegfried breaks ground on new R&D center for drug substances in Switzerland

The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists

Tissue engineered skin substitutes market to reach $3 billion by 2033, forecasts GlobalData

The burden of treating chronic wounds is growing rapidly due to increasing health care costs

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology

Chiesi Farmaceutici completes acquisition of Amryt Pharma

Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.

Thermo Fisher Scientific expands its capabilities in France

Bourgoin early development hub broadens offerings for oral solid dose formulations

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.

Bridgewest Group launches new sterile injectable CDMO NovaCina

Antibody-drug conjugates gain traction in China oncology market, says GlobalData

China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets